Company intelligence / Profile preview

PrecisionLife

Witney, England, United Kingdom

Ownership: Private
Employees: ~34
Development stage: Other

Overview

PrecisionLife is clinically applying its AI-driven multiomic analytics platform to deliver breakthrough insights, diagnostics, and treatment options for over 60 chronic diseases. It is supporting precision stratification of patients for clinical trials, predicting therapeutic response, and supporting the discovery of novel mechanisms and drug targets. Clinical results include improved diagnostic accuracy and actionable patient stratification in areas like long COVID, ME/CFS, and endometriosis.

Therapeutic areas: Infectious DiseasesWomen's HealthOtherNeurology
Modalities: Small moleculeBiologicDiagnostic testBiomarkerAI-based analytics
Industry: Drug Discovery Services

Partnerships

Pharmaceutical companiesBiopharma companiesGlobal healthcare systemsBiobanksDisease charitiesResearch consortia

Beyond the preview

Go deeper on PrecisionLife.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PrecisionLife.

Explore the full profile